Skip to Content
Merck

RAB0520

Bovine IFNG / Interferon Gamma ELISA Kit

for serum, plasma and cell culture supernatants

Sign In to View Organizational & Contract Pricing.

Select a Size

About This Item

NACRES:
NA.32
UNSPSC Code:
41116158

Key Documents

View All Documentation
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

Product Name

Bovine IFNG / Interferon Gamma ELISA Kit, for serum, plasma and cell culture supernatants

species reactivity

bovine

packaging

kit of 96 wells (12 strips x 8 wells)

technique(s)

ELISA: suitable

input

sample type cell culture supernatant(s)
sample type serum
sample type plasma

assay range

inter-assay cv: <10%
intra-assay cv: <12%
sensitivity: 0.11 ng/mL

detection method

colorimetric

shipped in

wet ice

storage temp.

−20°C

Gene Information

bovine ... IFNG(281237)

Related Categories

Application

For research use only. Not for use in diagnostic procedures.
Please refer to the attached General ELISA KIT Procedure (sandwich, competitive & Indirect ELISA)

General description

This ELISA antibody pair detects bovine Interferon Gamma.

Other Notes

A sample Certificate of Analysis is available for this product.
Please type the word sample in the text box provided for lot number.

pictograms

Corrosion
GHS05

signalword

Warning

hcodes

H290

Hazard Classifications

Met. Corr. 1

Storage Class

8A - Combustible corrosive hazardous materials

flash_point_f

Not applicable

flash_point_c

Not applicable

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
0207K0651
1013J0651
0810J0651
0401I0651
0622H0651

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Greta Garrido et al.
Frontiers in pharmacology, 8, 595-595 (2017-10-24)
Defining how epidermal growth factor receptor (EGFR)-targeting therapies influence the immune response is essential to increase their clinical efficacy. A growing emphasis is being placed on immune regulator genes that govern tumor - T cell interactions. Previous studies showed an
Janyra A Espinoza et al.
Journal of immunology (Baltimore, Md. : 1950), 199(1), 212-223 (2017-06-02)
Human respiratory syncytial virus (hRSV) is the leading cause of severe lower respiratory tract infections in children. The development of novel prophylactic and therapeutic antiviral drugs against hRSV is imperative to control the burden of disease in the susceptible population.
Kawaljit Kaur et al.
Oncoimmunology, 7(5), e1426518-e1426518 (2018-05-04)
Therapeutic role of NK cells in solid tumors was challenged previously even though their role in hematological malignancies has clearly been established. Furthermore, functions and numbers of NK cells are greatly suppressed in oral cancer patients necessitating effective future NK
Craig D Platt et al.
The Journal of allergy and clinical immunology, 140(6), 1651-1659 (2017-02-14)
Leucine-rich repeat containing 8A (LRRC8A) is an ubiquitously expressed transmembrane protein with 17 leucine-rich repeats (LRRs) at its C-terminal end and is an essential component of the volume-regulated anion channel (VRAC), which controls cellular volume. A heterozygous mutation in LRRC8A that
Ryosuke Uchiyama et al.
Journal of immunology (Baltimore, Md. : 1950), 199(3), 1122-1130 (2017-07-05)
CD4
View All Related Papers

Related Content

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service